Geoffrey Allen

1.9k total citations
42 papers, 1.2k citations indexed

About

Geoffrey Allen is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Geoffrey Allen has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 11 papers in Genetics and 1 paper in Surgery. Recurrent topics in Geoffrey Allen's work include Hemophilia Treatment and Research (37 papers), Platelet Disorders and Treatments (20 papers) and Blood Coagulation and Thrombosis Mechanisms (20 papers). Geoffrey Allen is often cited by papers focused on Hemophilia Treatment and Research (37 papers), Platelet Disorders and Treatments (20 papers) and Blood Coagulation and Thrombosis Mechanisms (20 papers). Geoffrey Allen collaborates with scholars based in United States, United Kingdom and South Africa. Geoffrey Allen's co-authors include Maureane Hoffman, Dougald M. Monroe, Harold R. Roberts, Alisa S. Wolberg, Glenn F. Pierce, Johnny Mahlangu, Ulla Hedner, J.A. Oliver, Beatrice Nolan and Guy Young and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and British Journal of Haematology.

In The Last Decade

Geoffrey Allen

41 papers receiving 1.2k citations

Peers

Countries citing papers authored by Geoffrey Allen

Since Specialization

Citations

This map shows the geographic impact of Geoffrey Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Allen more than expected).

Fields of papers citing papers by Geoffrey Allen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Allen. The network helps show where Geoffrey Allen may publish in the future.

Co-authorship network of co-authors of Geoffrey Allen

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Allen. A scholar is included among the top collaborators of Geoffrey Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Allen. Geoffrey Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of osivelotor in participants with sickle cell disease in a 12-week phase 2, multicenter, open-label, dose-finding trial and extension study 2025 ·Blood ·Santosh L. Saraf, Shehu U. Abdullahi, (unknown), (unknown), Modupe Idowu, (unknown), Serdar Alan, M. Patrick Stagg, (unknown), David R. Archer, (unknown), Aliya U. Zaidi, Patrick C. Hines, (unknown), Denis Rybin, Eric I. Zimmerman, (unknown), (unknown), Eleanor Lisbon, Geoffrey Allen	0
2	Immunogenicity, Efficacy and Safety of Rurioctocog Alfa Pegol in Previously Untreated Patients with Severe Hemophilia a: Interim Results from an Open-Label Multicenter Clinical Trial 2021 ·Blood ·Robert F. Sidonio, Christine Knoll, Flora Peyvandi, Oleksandra Stasyshyn, Bülent Antmen, (unknown), Darintr Sosothikul, (unknown), Werner Engl, Geoffrey Allen, Srilatha Tangada	3
3	Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A‐LONG study subjects with severe haemophilia A 2017 ·Haemophilia ·Amy D. Shapiro, Johnny Mahlangu, David J. Perry, John Pasi, Doris Quon, Pratima Chowdary, Elisa Tsao, (unknown), Alison Innes, Glenn F. Pierce, Geoffrey Allen	10
4	Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B 2016 ·Thrombosis and Haemostasis ·John Pasi, Kathelijn Fischer, Margaret V. Ragni, Beatrice Nolan, David J. Perry, Roshni Kulkarni, Margareth C. Ozelo, Johnny Mahlangu, Amy D. Shapiro, Ross Baker, Carolyn M. Bennett, (unknown), Johannes Oldenburg, Tadashi Matsushita, Huixing Yuan, (unknown), Glenn F. Pierce, Geoffrey Allen, Baisong Mei	29
5	Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A 2016 ·Thrombosis and Haemostasis ·Johnny Mahlangu, Margaret V. Ragni, Naresh Gupta, Savita Rangarajan, Robert Klamroth, Johannes Oldenburg, Keiji Nogami, Guy Young, Lynda M. Cristiano, Yingwen Dong, Geoffrey Allen, Glenn F. Pierce, Brian Robinson	38
6	Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A 2015 ·Journal of Thrombosis and Haemostasis ·Guy Young, Johnny Mahlangu, Roshni Kulkarni, Beatrice Nolan, Ri Liesner, John Pasi, Chris Barnes, Srividya Neelakantan, Giulia Gambino, Lynda M. Cristiano, Glenn F. Pierce, Geoffrey Allen	142
7	Long-lasting recombinant factor FIX Fc fusion (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study 2013 ·Journal of Thrombosis and Haemostasis ·Jerry S. Powell, Shashikant Apte, Hérvè Chambost, (unknown), Shaun P. Jackson, Neil C. Josephson, Johnny Mahlangu, (unknown), Kathelijne Peerlinck, Geoffrey Allen	4
8	Pharmacokinetics Of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Pediatric Subjects With Hemophilia A: An Interim Analysis Of The Kids A-LONG Study 2013 ·Blood ·Guy Young, Johnny Mahlangu, Beatrice Nolan, Simon Brown, Leonard A. Valentino, (unknown), Yingwen Dong, Lei Diao, Haiyan Jiang, Karen Nugent, Glenn F. Pierce, Geoffrey Allen	1
9	Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey 2012 ·Haemophilia ·(unknown), (unknown), (unknown), Geoffrey Allen	49
10	Eradication of factor viii inhibitors in patients with mild and moderate hemophilia A 2012 ·American Journal of Hematology ·Christine L. Kempton, Geoffrey Allen, Jeffrey D. Hord, (unknown), Rajiv K. Pruthi, Christopher Walsh, Guy Young, J. Michael Soucie	30
11	Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa) 2011 ·Journal of Thrombosis and Haemostasis ·Andreas Tiede, Ute Friedrich, (unknown), Geoffrey Allen, Paul Giangrande, Jenny Goudemand, C. R. M. Hay, Margareta Holmström, Robert Klamroth, Stefan Lethagen, Steven E. McKenzie, Wolfgang Miesbach, Claude Négrier, (unknown), Erik Berntorp	13
12	Transplacental transfer of postpartum inhibitors to factor VIII 2009 ·Haemophilia ·Rishi Lulla, Geoffrey Allen, Anaadriana Zakarija, (unknown)	25
13	High dose factor VIIa improves clot structure and stability in a model of haemophilia B 2005 ·British Journal of Haematology ·Alisa S. Wolberg, Geoffrey Allen, Dougald M. Monroe, Ulla Hedner, Harold R. Roberts, Maureane Hoffman	112
14	Therapeutic decision‐making in inhibitor patients 2005 ·American Journal of Hematology ·Geoffrey Allen, Louis M. Aledort	22
15	Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system 2004 ·Journal of Thrombosis and Haemostasis ·Geoffrey Allen, Alisa S. Wolberg, J.A. Oliver, Maureane Hoffman, Harold R. Roberts, Dougald M. Monroe	149
16	Approach to the bleeding child 2002 ·Pediatric Clinics of North America ·Geoffrey Allen, Bertil Glader	9
17	The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation 2000 ·Blood Coagulation & Fibrinolysis ·Geoffrey Allen, Dougald M. Monroe, Harold R. Roberts, Maureane Hoffman	32
18	The Factor VII-Platelet Interplay: Effectiveness of Recombinant Factor VIIa in the Treatment of Bleeding in Severe Thrombocytopathia 2000 ·Seminars in Thrombosis and Hemostasis ·Dougald M. Monroe, Maureane Hoffman, Geoffrey Allen, (unknown)	78
19	Anthropometric comparison of mentally retarded males with and without the fragile X syndrome 1991 ·American Journal of Medical Genetics ·Merlin G. Butler, Geoffrey Allen, (unknown), (unknown), Michael S. Watson, W. Roy Breg	30
20	The effect of chlortetracycline on the immune response. II. Influence on development of protective antibodies after vaccination with a live, avirulent strain of Erysipelothrix rhusiopathiae. 1959 ·PubMed ·Mark S. Cooper, Geoffrey Allen	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact